BriaCell Therapeutics Corp.
BCTX Nasdaq
SEC CIK 1610820
Follow BriaCell Therapeutics Corp.
Weekly email: filings, results, news
Net income
−$7.2M
−16.9% vs same quarter last year
EPS, diluted
−$0.99
+94% vs same quarter last year
Operating cash flow
−$7M
+2% vs same quarter last year
Operating income
−$7.6M
−20.4% vs same quarter last year
Source: SEC XBRL filings · latest filing
Show the numbers
| Year | Net income |
|---|---|
| FY25 | −$26.3M |
| FY24 | −$4.8M |
| FY23 | −$20.3M |
| FY22 | −$26.8M |
| FY21 | −$13.8M |
| FY20 | - |
News
No stories filed under BriaCell Therapeutics Corp. yet - coverage appears here as the news feed clusters it.